Author

Jiu-Da Zhao

h-index 23 View on Semantic Scholar

We have 2 of 144 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Expert Consensus on the Standardized Diagnosis, Treatment, and Management of Cancer in High‐Altitude Regions of China

ABSTRACT Cancer has become one of the major diseases threatening the health of the Chinese population. The incidence of cancer in high‐altitude regions of China is equally concerning. However, due to the unique geographical environment, population, and economic factors in high‐altitude regions, there is an urgent need...

Yi-Qun Li, Feng Li, Xiao-Rong Bai et al. · Cancer Innovation · 0 citations

Review Oct 2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Iza-bren significantly improved progression-free survival versus chemotherapy, and median progression-free survival assessed by Blinded Independent Central Review was 8·2 months (95% CI 6·9-8·6) versus 4·0 months (2·9-4·3; HR 0·41 [95% CI 0·33-0·53).

B. Lan, Ye-Hui Shi, Xi-Ying Shao et al. · The Lancet · 0 citations